Prognostic indicators for ewing's sarcoma

The Lancet

Volumn 376, Issue 9737, 2010, Pages 232-

  Tageja, Nishant ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; EWING SARCOMA; HISTOPATHOLOGY; HUMAN; LETTER; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 77955019846     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61141-5     Document Type: Letter

References (5)

1. Klieb HBE, Duchnay M, Skeete D, Leong IT, Blackstein ME. Painful palatal swelling. Lancet 2010; 375: 1224.
2. Hayes FA, Thompson EI, Meyer WH, et al. Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 1989; 7: 208-213
3. Marina NM, Pappo AS, Parham DM, et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round cell tumor: a feasibility study at St. Jude Children's Research Hospital. J Clin Oncol 1999; 17: 180-190
4. Bacci G, Ferrari S, Bertoni F, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ostopedico Rizzoli. J Clin Oncol 2000; 18: 4-11.
5. Paulussen M, Ahrens S, Dunst J, et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS-86. J Clin Oncol 2001; 19: 1818-1829